QuidelOrtho Formed by the Completion of Transaction Combining Quidel and Ortho Clinical Diagnostics
businesswire.com
news
2022-05-27 00:00:00

May 27, 2022 09:00 AM Eastern Daylight Time SAN DIEGO--(BUSINESS WIRE)--QuidelOrtho Corporation (NASDAQ: QDEL) ('QuidelOrtho') announced completion of the transaction combining Quidel Corporation ('Quidel') and Ortho Clinical Diagnostics Holdings plc ('Ortho'), creating QuidelOrtho, a leading in vitro diagnostics company. The new company, headquartered in San Diego, California, generated more than $3.5 billion in combined revenues in 2021 and has approximately 6,000 employees. QuidelOrtho will trade on the Nasdaq Global Select Market under the symbol 'QDEL.
